Quebec CHU, Quebec City, Quebec, Canada.
Adv Skin Wound Care. 2013 Sep;26(9):400-9. doi: 10.1097/01.ASW.0000433102.48268.2a.
Despite present optimal standard treatment of lower-extremity ulceration, a high incidence of recurrence and treatment failure is observed. The objective of this project was to evaluate the effect of a self-assembled skin substitute (SASS) made by tissue engineering as a temporary cutaneous dressing in the treatment of hard-to-heal chronic ulcers.
The prospective uncontrolled case study includes patients suffering from venous or mixed ulcers lasting more than 6 months and unresponsive to compression therapy, with an Ankle Brachial Index greater than 0.5. Compression therapy was combined with the weekly application of SASS, produced from the patient's own skin cells, until healing. A weekly follow-up recorded wound size, skin aspect, pain, drainage, and percentage of wound healing. Photographs were also taken to assess ulcer evolution.
Fourteen ulcers present on 5 patients were treated. A mean of 6.7 SASS depositions by ulcer was required for healing. Two ulcers developed a minor wound infection, which was treated with oral antibiotics; another 2 ulcers recurred, and 1 healed with a second course of treatment, whereas 1 ulcer had a small recurrence treated with local wound care.
The authors' study suggests that the SASS used as a biological dressing is a promising treatment for hard-to-heal chronic venous and mixed ulcers that are unresponsive to compression therapy.
尽管下肢溃疡目前采用了最佳的标准治疗方法,但仍观察到复发和治疗失败的发生率较高。本项目的目的是评估组织工程制成的自组装皮肤替代物(SASS)作为一种临时皮肤敷料在治疗难以愈合的慢性溃疡中的效果。
这项前瞻性非对照病例研究纳入了患有静脉或混合性溃疡且持续时间超过 6 个月、对加压治疗无反应、踝肱指数大于 0.5 的患者。将加压治疗与每周应用 SASS 联合治疗,SASS 由患者自身的皮肤细胞制成,直至愈合。每周记录伤口大小、皮肤状况、疼痛、渗液和伤口愈合百分比。还拍摄了照片以评估溃疡的演变。
5 名患者的 14 个溃疡得到了治疗。平均每个溃疡需要进行 6.7 次 SASS 沉积才能愈合。有 2 个溃疡发生了轻微的伤口感染,用口服抗生素治疗;另外 2 个溃疡复发,1 个溃疡经第二次治疗愈合,而 1 个溃疡经局部伤口护理治疗后出现了小的复发。
作者的研究表明,作为生物敷料使用的 SASS 是一种有前途的治疗方法,可用于治疗对加压治疗无反应的难以愈合的慢性静脉和混合性溃疡。